Black Diamond Therapeutics I

Penny Stocks Biotech Stocks Healthcare Stocks

$2.11

+0.08 (+3.94%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 13 87%

Hold 2 13%

Sell 0 0%

Price Target

Analyst Price Target +1,602.4% upside

Low Target $30.62

Average Target $35.92

High Target $44.24

Current Price $2.11

Current
$2.11

Target
$35.92

$30.62 $35.92 avg $44.24

Scenario Analysis

Bear Case

$30.62

1,351.2%

Low target

Base Case

$35.92

+1,602.4%

Avg target

Bull Case

$44.24

+1,996.7%

High target

Risk/Reward

1.5x

Balanced

Price in Context

52-Week High

$4.94

-57.3% from high

52-Week Low

$1.20

+76.6% from low

Target vs 52W High

$35.92

+627.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.9%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+157.7%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.5%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.0%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.5%